← Browse by Condition
Medical Condition

spinal cord injury

Total Trials
13
Recruiting Now
13
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for spinal cord injury sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — spinal cord injury Clinical Trials

How many clinical trials are currently recruiting for spinal cord injury?
ClinicalMetric currently tracks 13 actively recruiting clinical trials for spinal cord injury, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 13. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for spinal cord injury?
spinal cord injury research spans Phase 1 (2 trials), Phase 2 (3 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a spinal cord injury clinical trial?
Eligibility criteria for spinal cord injury trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
3
Phase 3
1
Top Sponsors
Ankara City Hospital Bilkent 2 trials
University of British Columbia 2 trials
Swiss Paraplegic Research, Nottwil 1 trial
University of Minnesota 1 trial
Buddhist Tzu Chi General Hospital 1 trial

Recruiting Clinical Trials

NCT06876285
Recruiting
Effects of Wheelchair Treadmill and Conventional Exercises on Trunk Balance in Spinal Cord Injury Patients
Enrollment
20 pts
Location
Turkey (Türkiye)
Sponsor
Ankara City Hospital Bilkent
View Trial →
NCT06892080
Recruiting
Urine Incontinence Occurrence and Sexual Hormones in Women With Chronic Spinal Cord Injury/Disease - a Pilot Study
Enrollment
24 pts
Location
Switzerland
Sponsor
Swiss Paraplegic Research, Not...
View Trial →
NCT06410001 Phase 1, Phase 2
Recruiting
CE-STAND: Cervical Epidural STimulation After Neurologic Damage
Enrollment
36 pts
Location
United States
Sponsor
University of Minnesota
View Trial →
NCT07429305
Recruiting
Combined Tibial Nerve Stimulation and Standing for People With SCI
Enrollment
12 pts
Location
Canada
Sponsor
University of British Columbia
View Trial →
NCT07343583
Recruiting
Effects of Sacral and Tibial Stimulation on Bladder Function in Subacute Suprasacral Spinal Cord Injury
Enrollment
45 pts
Location
Turkey (Türkiye)
Sponsor
Ankara City Hospital Bilkent
View Trial →
NCT05638191
Recruiting
Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury
Enrollment
40 pts
Location
Canada
Sponsor
University of British Columbia
View Trial →
NCT05433064
Recruiting
Spinal Cord Stimulation for Spinal Cord Injury Patients - Regain Walk and Alleviate Pain
Enrollment
12 pts
Location
Taiwan
Sponsor
Buddhist Tzu Chi General Hospi...
View Trial →
NCT07550699
Recruiting
Clinical Investigation to Validate the Safety and Performance of Integrating Functional Electrical Stimulation Into the ABLE Exoskeleton
Enrollment
15 pts
Location
Austria
Sponsor
ABLE Human Motion S.L.
View Trial →
NCT06922890 Phase 1, Phase 2
Recruiting
First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury
Enrollment
9 pts
Location
South Korea
Sponsor
Yonsei University
View Trial →
NCT07663266
Recruiting
Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury
Enrollment
14 pts
Location
United States
Sponsor
University of Michigan
View Trial →
NCT07127172
Recruiting
GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
Enrollment
7 pts
Location
United Kingdom
Sponsor
Neuralink Corp
View Trial →
NCT06867809
Recruiting
Spine and Brain Stimulation for Movement Recovery After Cervical Spinal Cord Injury
Enrollment
20 pts
Location
United States
Sponsor
Jason Carmel
View Trial →
NCT07625332 Phase 2, Phase 3
Recruiting
Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
Enrollment
60 pts
Location
United States
Sponsor
Northwell Health
View Trial →

Related Conditions

cervical spinal cord injury (2) multiple sclerosis (2) urinary incontinence (1) menstrual cycle (1) detrusor overacitivity (1) spinal cord injury at c5 c7 level (1) sci spinal cord injury (1) upper extremity paralysis (1) upper extremity dysfunction (1) tetraplegia (1) upper extremity paresis (1) acquired brain injury including stroke (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology